WhatsApp-Image-2026-04-11-at-7.18.28-AM (48)

SURVORID-H® Tablets

SURVORID-H® Tablets
Generic Name:
Levosulpiride
Therapeutic Group:
Gastrointestinal (GI) Disorders
Drug Category:
Prokinetic Agent / Dopamine D₂ Receptor Antagonist
Content / Composition:
Each tablet contains:
* Levosulpiride …… 50 mg
Indications:
Indicated for the management of:
* Functional dyspepsia
* Irritable Bowel Syndrome (IBS)
* Gastroesophageal Reflux Disease (GERD)
* Delayed gastric emptying (gastroparesis)
* Nausea and vomiting associated with GI disorders
Dosage:
As directed by the physician.
Typical dosing:
* 25–50 mg, 2–3 times daily before meals
* Dose may vary depending on severity and patient response
Contraindications:
* Hypersensitivity to levosulpiride
* Gastrointestinal hemorrhage, obstruction, or perforation
* Pheochromocytoma
* Epilepsy or seizure disorders
* Prolactin-dependent tumors (e.g., prolactinoma)
Administration:
For oral use.
* Preferably taken before meals
* Swallow with adequate water
* Follow physician’s instructions strictly
Interaction:
* CNS depressants → enhanced sedative effects
* Antihypertensives → additive hypotensive effect
* Dopaminergic drugs (e.g., levodopa) → reduced efficacy
* Alcohol → increased CNS side effects
Compatibility:
Compatible with most GI medications (PPIs, antacids)
Avoid combination with strong CNS depressants where possible
Stability / Storage:
Store below 25°C
Protect from light and moisture
Keep out of reach of children
Precautions:
* Use cautiously in renal impairment (dose adjustment may be required)
* Monitor for extrapyramidal symptoms
* May increase prolactin levels (hyperprolactinemia risk)
* Use with caution in elderly patients
* Avoid prolonged use without medical supervision
Side Effects:
Common:
* Drowsiness
* Fatigue
* Dizziness
Less common:
* Constipation or diarrhea
* Headache
Serious (rare):
* Extrapyramidal symptoms (tremor, rigidity)
* Hyperprolactinemia (galactorrhea, gynecomastia)
* Menstrual irregularities
Professional Web Note:
Levosulpiride is a selective dopamine D₂ receptor antagonist with dual prokinetic and anti-dyspeptic action, enhancing gastrointestinal motility while improving gut–brain axis function, making it highly effective in functional GI disorders.

Tags: No tags

Comments are closed.